SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-002159
Filing Date
2018-02-09
Accepted
2018-02-09 16:09:31
Documents
52
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20171231_10q.htm 10-Q 850096
2 EXHIBIT 31.1 CERTIFICATION OF CEO ex_104304.htm EX-31.1 14178
3 EXHIBIT 31.2 CERTIFICATION OF CFO ex_104305.htm EX-31.2 14049
4 EXHIBIT 32.1 CERTIFICATION OF PERIODIC REPORT CEO ex_104306.htm EX-32.1 7094
5 EXHIBIT 32.2 CERTIFICATION OF PERIODIC REPORT CFO ex_104307.htm EX-32.2 6606
  Complete submission text file 0001437749-18-002159.txt   4180092

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20171231.xml EX-101.INS 928403
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20171231.xsd EX-101.SCH 41309
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20171231_cal.xml EX-101.CAL 37513
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20171231_def.xml EX-101.DEF 270245
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20171231_lab.xml EX-101.LAB 235222
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20171231_pre.xml EX-101.PRE 285518
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 18591805
SIC: 2834 Pharmaceutical Preparations